Mei-Yin Polley to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Mei-Yin Polley has written about Dose-Response Relationship, Drug.
Connection Strength
0.331
-
Two-stage designs for dose-finding trials with a biologic endpoint using stepwise tests. Biometrics. 2008 Mar; 64(1):232-41.
Score: 0.225
-
Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities. Stat Med. 2011 Jul 30; 30(17):2130-43.
Score: 0.074
-
Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance). Cancer. 2019 10 01; 125(19):3378-3389.
Score: 0.032